These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 24904738)

  • 41. In vitro and in vivo activity of R547: a potent and selective cyclin-dependent kinase inhibitor currently in phase I clinical trials.
    DePinto W; Chu XJ; Yin X; Smith M; Packman K; Goelzer P; Lovey A; Chen Y; Qian H; Hamid R; Xiang Q; Tovar C; Blain R; Nevins T; Higgins B; Luistro L; Kolinsky K; Felix B; Hussain S; Heimbrook D
    Mol Cancer Ther; 2006 Nov; 5(11):2644-58. PubMed ID: 17121911
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
    Santamaria D; Ortega S
    Front Biosci; 2006 Jan; 11():1164-88. PubMed ID: 16146805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-beta.
    Ravitz MJ; Wenner CE
    Adv Cancer Res; 1997; 71():165-207. PubMed ID: 9111866
    [TBL] [Abstract][Full Text] [Related]  

  • 44. G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells.
    Gao N; Flynn DC; Zhang Z; Zhong XS; Walker V; Liu KJ; Shi X; Jiang BH
    Am J Physiol Cell Physiol; 2004 Aug; 287(2):C281-91. PubMed ID: 15028555
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs.
    Roskoski R
    Pharmacol Res; 2019 Jan; 139():471-488. PubMed ID: 30508677
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of roscovitine, a selective CDK inhibitor, on cancer cells: bi-functionality increases its therapeutic potential.
    Wesierska-Gadek J; Borza A; Komina O; Maurer M
    Acta Biochim Pol; 2009; 56(3):495-501. PubMed ID: 19724778
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extracellular matrix-dependent myosin dynamics during G1-S phase cell cycle progression in hepatocytes.
    Bhadriraju K; Hansen LK
    Exp Cell Res; 2004 Nov; 300(2):259-71. PubMed ID: 15474992
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hyposmotic stress induces cell growth arrest via proteasome activation and cyclin/cyclin-dependent kinase degradation.
    Tao GZ; Rott LS; Lowe AW; Omary MB
    J Biol Chem; 2002 May; 277(22):19295-303. PubMed ID: 11897780
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
    Liang YC; Lin-Shiau SY; Chen CF; Lin JK
    J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells.
    Ahmad N; Adhami VM; Afaq F; Feyes DK; Mukhtar H
    Clin Cancer Res; 2001 May; 7(5):1466-73. PubMed ID: 11350919
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15.
    Iavarone A; Massagué J
    Nature; 1997 May; 387(6631):417-22. PubMed ID: 9163429
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phylogenetic analysis of cell-cycle regulatory proteins within the Symbiodiniaceae.
    Gorman LM; Wilkinson SP; Kitchen SA; Oakley CA; Grossman AR; Weis VM; Davy SK
    Sci Rep; 2020 Nov; 10(1):20473. PubMed ID: 33235281
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insulin-like growth factor binding protein-3 induces G1 cell cycle arrest with inhibition of cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cells.
    Kim HS; Lee WJ; Lee SW; Chae HW; Kim DH; Oh Y
    Horm Metab Res; 2010 Mar; 42(3):165-72. PubMed ID: 19960406
    [TBL] [Abstract][Full Text] [Related]  

  • 54. E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components.
    Kim NG; Koh E; Chen X; Gumbiner BM
    Proc Natl Acad Sci U S A; 2011 Jul; 108(29):11930-5. PubMed ID: 21730131
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cooperation of p27(Kip1) and p18(INK4c) in progestin-mediated cell cycle arrest in T-47D breast cancer cells.
    Swarbrick A; Lee CS; Sutherland RL; Musgrove EA
    Mol Cell Biol; 2000 Apr; 20(7):2581-91. PubMed ID: 10713180
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.
    Deep G; Singh RP; Agarwal C; Kroll DJ; Agarwal R
    Oncogene; 2006 Feb; 25(7):1053-69. PubMed ID: 16205633
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glucocorticoid receptor-mediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms.
    Rogatsky I; Trowbridge JM; Garabedian MJ
    Mol Cell Biol; 1997 Jun; 17(6):3181-93. PubMed ID: 9154817
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulation of glioblastoma progression by cord blood stem cells is mediated by downregulation of cyclin D1.
    Velpula KK; Dasari VR; Tsung AJ; Gondi CS; Klopfenstein JD; Mohanam S; Rao JS
    PLoS One; 2011 Mar; 6(3):e18017. PubMed ID: 21455311
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Indigo naturalis and its component tryptanthrin exert anti-angiogenic effect by arresting cell cycle and inhibiting Akt and FAK signaling in human vascular endothelial cells.
    Chang HN; Huang ST; Yeh YC; Wang HS; Wang TH; Wu YH; Pang JH
    J Ethnopharmacol; 2015 Nov; 174():474-81. PubMed ID: 26341616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. UCN-01-induced cell cycle arrest requires the transcriptional induction of p21(waf1/cip1) by activation of mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway.
    Facchinetti MM; De Siervi A; Toskos D; Senderowicz AM
    Cancer Res; 2004 May; 64(10):3629-37. PubMed ID: 15150122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.